Literature DB >> 2374680

A prospective study on the implantation of anterior chamber intraocular lenses during keratoplasty for pseudophakic and aphakic bullous keratopathy.

G W Zaidman1, S Goldman.   

Abstract

Between April 1986 and April 1989, the authors conducted a prospective study of the use of open-loop anterior chamber intraocular lenses (AC IOLs) in patients undergoing penetrating keratoplasty for pseudophakic bullous keratopathy or monocular aphakic bullous keratopathy. All patients underwent the same operation--a penetrating keratoplasty combined with insertion of an open-loop AC IOL. Pseudophakic patients had an IOL exchange at the time of surgery. Thirty-six patients have been followed an average of 15 months. Thirty-two (89%) of the grafts are clear. Preoperatively, 100% of eyes had visual acuity less than 20/200. Postoperatively, 11 eyes (31%) have visual acuity better than 20/40 and 23 eyes (64%) have visual acuity better than 20/100. The most common causes for visual acuity less than 20/200 were cystoid macular edema, glaucoma, and immunologic graft failure. Using open-loop AC IOLs in patients with pseudophakic or aphakic bullous keratopathy can give good postoperative results and functional vision.

Entities:  

Mesh:

Year:  1990        PMID: 2374680     DOI: 10.1016/s0161-6420(90)32513-7

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  3 in total

1.  Glued intraocular lens with descemet stripping endothelial keratoplasty in aphakic bullous keratopathy.

Authors:  Anita Mani; P S Moulick; Alok Sati; Sandeep Gupta
Journal:  Med J Armed Forces India       Date:  2017-01-03

2.  Long-term results of penetrating keratoplasty. A 10-year-plus retrospective study.

Authors:  Marc Muraine; Christian Sanchez; Laure Watt; Alain Retout; Gérard Brasseur
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-06-18       Impact factor: 3.117

3.  Posterior lamellar graft preparation: a prospective review from an eye bank on current and future aspects.

Authors:  Mohit Parekh; Gianni Salvalaio; Alessandro Ruzza; Davide Camposampiero; Carlo Griffoni; Alfonso Zampini; Diego Ponzin; Stefano Ferrari
Journal:  J Ophthalmol       Date:  2013-05-30       Impact factor: 1.909

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.